The utility of the macro-aggregated albumin lung perfusion scan in the diagnosis and prognosis of hepatopulmonary syndrome in cirrhotic patients candidates for liver transplantation

Autor: Israel Grilo, Francisco-Jesús López-Pardo, M.T. Ferrer, Antonio Grilo Reina, J.M. Sousa, Francisco Ortega-Ruiz, Juan Manuel Pascasio, Juan Luis Tirado, Miguel Ángel Gómez-Bravo, María J. Rodríguez-Puras
Rok vydání: 2017
Předmět:
Liver Cirrhosis
Male
medicine.medical_treatment
030230 surgery
Liver transplantation
Severity of Illness Index
Gastroenterology
Hypoxemia
0302 clinical medicine
Prospective Studies
030212 general & internal medicine
Respiratory system
Hypoxia
Prospective cohort study
Hepatopulmonary syndrome
Lung
Ascites
Organotechnetium Compounds
General Medicine
Middle Aged
respiratory system
Prognosis
Survival Rate
Cirrhosis
Echocardiography
Pulmonary vascular diseases
Female
medicine.symptom
Adult
medicine.medical_specialty
Sensitivity and Specificity
Preoperative care
03 medical and health sciences
Albumins
Internal medicine
Preoperative Care
Contrast echocardiography
otorhinolaryngologic diseases
medicine
Humans
lcsh:RC799-869
Radionuclide Imaging
Survival rate
business.industry
medicine.disease
Liver Transplantation
Surgery
Concomitant
lcsh:Diseases of the digestive system. Gastroenterology
Radiopharmaceuticals
business
Follow-Up Studies
Hepatopulmonary Syndrome
Perioperative care
Zdroj: Revista Española de Enfermedades Digestivas, Volume: 109, Issue: 5, Pages: 335-343, Published: MAY 2017
Revista Española de Enfermedades Digestivas v.109 n.5 2017
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Revista Espanola de Enfermedades Digestivas, Vol 109, Iss 5, Pp 335-343
ISSN: 1130-0108
DOI: 10.17235/reed.2017.4219/2016
Popis: Background: The macro-aggregated albumin lung perfusion scan (99mTc-MAA) is a diagnostic method for hepatopulmonary syndrome (HPS). Aim: To determine the sensitivity of 99mTc-MAA in diagnosing HPS, to establish the utility of 99mTc-MAA in determining the influence of HPS on hypoxemia in patients with concomitant pulmonary disease and to determine the correlation between 99mTc-MAA values and other respiratory parameters. Methods: Data from 115 cirrhotic patients who were eligible for liver transplantation (LT) were prospectively analyzed. A transthoracic contrast echocardiography and 99mTc-MAA were performed in 85 patients, and 74 patients were diagnosed with HPS. Results: The overall sensitivity of 99mTc-MAA for the diagnosis of HPS was 18.9% (14/74) in all of the HPS cases and 66.7% (4/6) in the severe to very severe cases. In HPS patients who did not have lung disease, the degree of brain uptake of 99mTc-MAA was correlated with the alveolar-arterial oxygen gradient (A-a PO2) (r = 0.32, p < 0.05) and estimated oxygen shunt (r = 0.41, p < 0.05) and inversely correlated with partial pressure of arterial oxygen (PaO2) while breathing 100% O2 (r = -0.43, p < 0.05). The 99mTc-MAA was positive in 20.6% (7/36) of the patients with HPS and lung disease. The brain uptake of 99mTc-MAA was not associated with mortality and normalized in all cases six months after LT. Conclusions: The 99mTc-MAA is a low sensitivity test for the diagnosis of HPS that can be useful in patients who have concomitant lung disease and in severe to very severe cases of HPS. It was not related to mortality, and brain uptake normalized after LT.
Databáze: OpenAIRE